Cristian Hernández-Rocha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Cristian Hernández-Rocha has a total of 193 co-authors. Here are the top co-authors by number of shared publications:
Manuel Álvarez-Lobos
Departamento de Gastroenterología, Pontificia Universidad Católica de Chile, Santiago, Chile
9 shared publications- Daniel Paredes-Sabja
Department of Biology, Texas A&M University, College Station, Texas, USA
7 shared publications - Jonathan Barra-Carrasco
Laboratorio de Mecanismos de Patogénesis Bacteriana, Departamento de Ciencias Biológicas, Facultad de Ciencias Biológicas, Universidad Andrés Bello, República 217, Santiago, Chile
7 shared publications - Joanne M. Stempak
Zane Cohen Centre for Digestive Diseases, Division of Gastroenterology, Mount Sinai Hospital, Sinai Health , Toronto, Ontario
5 shared publications - Krzysztof Borowski
Zane Cohen Centre for Digestive Diseases, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada
5 shared publications - Mark S. Silverberg
Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Canada
5 shared publications
Latest Publications
- Open Access
- 9 October 2026
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 20 (10)
Exploration of international differences in preoperative characteristics, indications, postoperative management and endoscopic recurrence rates in patients with Crohn’s disease following ileocolic (re-)resection: first outcomes from the IMPACT consortium
Background: Reports on postoperative outcomes after ileocolic resection (ICR) in Crohn’s disease (CD) vary widely. To provide insights into these differences, we compared international data on preoperative characteristics and postoperative management and outcome. Methods: CD patients undergoing ICR were included from prospective cohort studies in the Netherlands (NL), France (FR), Canada (CAN), and United States of America (USA). Results: Among 1761 patients, 79% underwent primary resection. In this population, surgery for Montreal classification B1 disease was more common (22% vs 0%-5%) and performed after shorter disease duration (4.3 vs 6.2-7.1 years) in NL than in other cohorts. Active smoking was more prevalent in NL and FR than in CAN and USA (23%-34% vs 7%-13%). In CAN, 54% were biologic-naive versus 27%-36% in other cohorts. Postoperative prophylaxis was prescribed in 28% of patients in NL and CAN, compared with 48% in FR and USA. Ileocolonoscopy within 12 months was performed in 72% in USA versus 88% in other cohorts. In the re-resection population, B1 disease at surgery and disease duration did not differ, whereas other findings were similar. Endoscopic postoperative recurrence (modified Rutgeerts’ score ≥ i2b) varied from 36% in FR to 41% in NL, 15% in USA to 24% in CAN after primary resection and from 43% in NL, 46% in FR, 26% in CAN to 29% in USA cohort after re-resection. Conclusions: Notable differences in preoperative characteristics and postoperative management and outcomes for ileocolic (re-)resections in CD were observed across European and North American countries.
- 9 October 2026
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 20 (10)
Open AccessExploration of international differences in preoperative characteristics, indications, postoperative management and endoscopic recurrence rates in patients with Crohn’s disease following ileocolic (re-)resection: first outcomes from the IMPACT consortium
Background: Reports on postoperative outcomes after ileocolic resection (ICR) in Crohn’s disease (CD) vary widely. To provide insights into these differences, we compared international data on preoperative characteristics and postoperative management and outcome. Methods: CD patients undergoing ICR were included from prospective cohort studies in the Netherlands (NL), France (FR), Canada (CAN), and United States of America (USA). Results: Among 1761 patients, 79% underwent primary resection. In this population, surgery for Montreal classification B1 disease was more common (22% vs 0%-5%) and performed after shorter disease duration (4.3 vs 6.2-7.1 years) in NL than in other cohorts. Active smoking was more prevalent in NL and FR than in CAN and USA (23%-34% vs 7%-13%). In CAN, 54% were biologic-naive versus 27%-36% in other cohorts. Postoperative prophylaxis was prescribed in 28% of patients in NL and CAN, compared with 48% in FR and USA. Ileocolonoscopy within 12 months was performed in 72% in USA versus 88% in other cohorts. In the re-resection population, B1 disease at surgery and disease duration did not differ, whereas other findings were similar. Endoscopic postoperative recurrence (modified Rutgeerts’ score ≥ i2b) varied from 36% in FR to 41% in NL, 15% in USA to 24% in CAN after primary resection and from 43% in NL, 46% in FR, 26% in CAN to 29% in USA cohort after re-resection. Conclusions: Notable differences in preoperative characteristics and postoperative management and outcomes for ileocolic (re-)resections in CD were observed across European and North American countries.
- Open Access
- 24 August 2026
- Published by Sociedad de Gastroenterologia del Peru in Revista de Gastroenterología del Perú
- Vol. 46 (3) , 249-256
Risk factors for thiopurine-related toxicity in Latin American inflammatory bowel disease patients
Objectives: Thiopurines continue to play a role in inflammatory bowel disease (IBD) treatment, particularly in resource-limited countries. However, there are scarce data from Latin America regarding thiopurines-associated AE. We aim to describe the thiopurine-associated AE and determine risk factors for its occurrence. Materials and methods: Clinical data from IBD patients treated with thiopurines in a Chilean tertiary centre were retrospectively collected including AE that required thiopurine withdrawal and weight-based thiopurine dose. A multivariable model was fitted to determine independent risk factors of thiopurine-related AE. Odds ratios (OR) and 95% confidence intervals (CI) were calculated. Results: A total 163 out of 587 (27.7%) patients discontinued thiopurine treatment due to AE including myelosuppression, hepatitis, pancreatitis, and gastrointestinal intolerance. Multivariate analysis showed that older age (OR: 1.02; 95% CI: 1.01-1.04; p=0.01) and lower body weight (OR: 0.97; 95% CI: 0.95-0.99; p=0.01) were independent risk factors for thiopurine-associated AE. Conclusions: Discontinuation of thiopurines due to AE is frequent in Latin IBD patients. Particular caution should be exerted in older and low-weight IBD patients starting thiopurine treatment.
- 24 August 2026
- Published by Sociedad de Gastroenterologia del Peru in Revista de Gastroenterología del Perú
- Vol. 46 (3) , 249-256
Open AccessRisk factors for thiopurine-related toxicity in Latin American inflammatory bowel disease patients
Objectives: Thiopurines continue to play a role in inflammatory bowel disease (IBD) treatment, particularly in resource-limited countries. However, there are scarce data from Latin America regarding thiopurines-associated AE. We aim to describe the thiopurine-associated AE and determine risk factors for its occurrence. Materials and methods: Clinical data from IBD patients treated with thiopurines in a Chilean tertiary centre were retrospectively collected including AE that required thiopurine withdrawal and weight-based thiopurine dose. A multivariable model was fitted to determine independent risk factors of thiopurine-related AE. Odds ratios (OR) and 95% confidence intervals (CI) were calculated. Results: A total 163 out of 587 (27.7%) patients discontinued thiopurine treatment due to AE including myelosuppression, hepatitis, pancreatitis, and gastrointestinal intolerance. Multivariate analysis showed that older age (OR: 1.02; 95% CI: 1.01-1.04; p=0.01) and lower body weight (OR: 0.97; 95% CI: 0.95-0.99; p=0.01) were independent risk factors for thiopurine-associated AE. Conclusions: Discontinuation of thiopurines due to AE is frequent in Latin IBD patients. Particular caution should be exerted in older and low-weight IBD patients starting thiopurine treatment.
- Open Access
- 20 August 2025
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 20 (6)
Micronutrients are associated with endoscopic postoperative recurrence in Crohn’s disease: a multicenter prospective cohort study in North america
Background and Aims: Diet may influence the disease course in inflammatory bowel disease, but its role in postoperative outcomes for Crohn’s disease (CD) remains unclear. This study aimed to assess the association of macro- and micronutrient intake with endoscopic postoperative recurrence (ePOR) in a prospective multicenter cohort. Methods: Patients with CD following ileocolic resection were prospectively recruited from six North American centers. Primary study outcome was ePOR (modified Rutgeerts’ score ≥i2a) during follow-up. Nutritional intake was assessed through two-day food diaries verified by dietitian-delivered interview. Associations between nutrient intake and ePOR were evaluated. Random forest models with 10-fold cross-validation assessed the predictive value of nutrients and clinical factors for ePOR. Results: A total of 520 food diaries from 103 patients were analyzed; 37 patients (36%) experienced ePOR. Univariate analysis identified eight nutrients associated with ePOR including lower intake of isoflavones (genistein, daidzein, glycitein; p < 0.01), inositol (p < 0.01), pinitol (p = 0.02), provitamin-A carotenoid (p < 0.01), xylitol (p = 0.03) and parinaric Acid (p = 0.03). Sensitivity analysis confirmed the association of lower intake of all isoflavones (p < 0.01) and pinitol (p = 0.04) with ePOR at first postoperative colonoscopy. Random forest models showed poor discrimination for clinical factors alone (AUC 0.59) but an acceptable discrimination for nutrients alone (AUC 0.67), which improved when combining nutrients and clinical factors (AUC 0.71). Conclusion: Lower intake of specific micronutrients is associated with ePOR in CD patients. A machine-learning model combining nutrient intake and clinical factors enhanced the prediction of ePOR. These findings highlight the importance of postoperative nutritional assessment and suggest dietary interventions may help prevent postoperative recurrence in CD.
- 20 August 2025
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 20 (6)
Open AccessMicronutrients are associated with endoscopic postoperative recurrence in Crohn’s disease: a multicenter prospective cohort study in North america
Background and Aims: Diet may influence the disease course in inflammatory bowel disease, but its role in postoperative outcomes for Crohn’s disease (CD) remains unclear. This study aimed to assess the association of macro- and micronutrient intake with endoscopic postoperative recurrence (ePOR) in a prospective multicenter cohort. Methods: Patients with CD following ileocolic resection were prospectively recruited from six North American centers. Primary study outcome was ePOR (modified Rutgeerts’ score ≥i2a) during follow-up. Nutritional intake was assessed through two-day food diaries verified by dietitian-delivered interview. Associations between nutrient intake and ePOR were evaluated. Random forest models with 10-fold cross-validation assessed the predictive value of nutrients and clinical factors for ePOR. Results: A total of 520 food diaries from 103 patients were analyzed; 37 patients (36%) experienced ePOR. Univariate analysis identified eight nutrients associated with ePOR including lower intake of isoflavones (genistein, daidzein, glycitein; p < 0.01), inositol (p < 0.01), pinitol (p = 0.02), provitamin-A carotenoid (p < 0.01), xylitol (p = 0.03) and parinaric Acid (p = 0.03). Sensitivity analysis confirmed the association of lower intake of all isoflavones (p < 0.01) and pinitol (p = 0.04) with ePOR at first postoperative colonoscopy. Random forest models showed poor discrimination for clinical factors alone (AUC 0.59) but an acceptable discrimination for nutrients alone (AUC 0.67), which improved when combining nutrients and clinical factors (AUC 0.71). Conclusion: Lower intake of specific micronutrients is associated with ePOR in CD patients. A machine-learning model combining nutrient intake and clinical factors enhanced the prediction of ePOR. These findings highlight the importance of postoperative nutritional assessment and suggest dietary interventions may help prevent postoperative recurrence in CD.
- 27 June 2025
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 24 (5) , 1471-1472
Letter to the Editor Regarding Ioannou et al
- 27 June 2025
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 24 (5) , 1471-1472
Letter to the Editor Regarding Ioannou et al
- Open Access
- 15 June 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (12) , 5741
Prediction of Extraintestinal Manifestations in Inflammatory Bowel Disease Using Clinical and Genetic Variables with Machine Learning in a Latin IBD Group
Extraintestinal manifestations (EIMs) significantly increase morbidity in inflammatory bowel disease (IBD) patients. In this study, we examined clinical and genetic factors associated with EIMs in 414 Latin IBD patients, utilizing machine learning for predictive modeling. In our IBD group (314 ulcerative colitis (UC) and 100 Crohn’s disease (CD) patients), EIM presence was assessed. Clinical differences between patients with and without EIMs were analyzed using Chi-square and Mann–Whitney U tests. Based on the genetic data of 232 patients, we identified variants linked to EIMs, and the polygenic risk score (PRS) was calculated. A machine learning approach based on logistic regression (LR), random forest (RF), and gradient boosting (GB) models was employed for predicting EIMs. EIMs were present in 29% (120/414) of patients. EIM patients were older (52 vs. 45 years, p = 0.01) and were more likely to have a family history of IBD (p = 0.02) or use anti-TNF therapy (p = 0.01). EIMs were more common in patients with CD than in those with UC without reaching statistical significance (p = 0.06). Four genetic variants were associated with EIM risk (rs9936833, rs4410871, rs3132680, and rs3823417). While the PRS showed limited predictive power (AUC = 0.69), the LR, GB, and RF models demonstrated good predictive capabilities. Approximately one-third of IBD patients experienced EIMs. Significant risk factors included genetic variants, family history, age, and anti-TNF therapy, with predictive models effectively identifying EIM risk.
- 15 June 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (12) , 5741
Open AccessPrediction of Extraintestinal Manifestations in Inflammatory Bowel Disease Using Clinical and Genetic Variables with Machine Learning in a Latin IBD Group
Extraintestinal manifestations (EIMs) significantly increase morbidity in inflammatory bowel disease (IBD) patients. In this study, we examined clinical and genetic factors associated with EIMs in 414 Latin IBD patients, utilizing machine learning for predictive modeling. In our IBD group (314 ulcerative colitis (UC) and 100 Crohn’s disease (CD) patients), EIM presence was assessed. Clinical differences between patients with and without EIMs were analyzed using Chi-square and Mann–Whitney U tests. Based on the genetic data of 232 patients, we identified variants linked to EIMs, and the polygenic risk score (PRS) was calculated. A machine learning approach based on logistic regression (LR), random forest (RF), and gradient boosting (GB) models was employed for predicting EIMs. EIMs were present in 29% (120/414) of patients. EIM patients were older (52 vs. 45 years, p = 0.01) and were more likely to have a family history of IBD (p = 0.02) or use anti-TNF therapy (p = 0.01). EIMs were more common in patients with CD than in those with UC without reaching statistical significance (p = 0.06). Four genetic variants were associated with EIM risk (rs9936833, rs4410871, rs3132680, and rs3823417). While the PRS showed limited predictive power (AUC = 0.69), the LR, GB, and RF models demonstrated good predictive capabilities. Approximately one-third of IBD patients experienced EIMs. Significant risk factors included genetic variants, family history, age, and anti-TNF therapy, with predictive models effectively identifying EIM risk.
- Open Access
- 9 July 2024
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 18 (12) , 1957-1966
Inflammatory Bowel Disease Associated with Primary Sclerosing Cholangitis is Associated with an Altered Gut Microbiome and Bile Acid Profile
Primary sclerosing cholangitis associated with inflammatory bowel disease (IBD-PSC) carries significant morbidity compared to IBD without PSC. Alterations in microbial composition and bile acid (BA) profiles have been shown to modulate chronic inflammation in IBD, but data in IBD-PSC is scarce. We aimed to assess the differences in gut microbiome composition as well as in the BA profile and BA-related microbial functions between IBD-PSC and IBD-only. 54 IBD-PSC and 62 IBD-only subjects were enrolled from 2012 to 2021. Baseline samples were collected for fecal DNA shotgun metagenomic sequencing, fecal and serum BA quantitation using mass spectrometry and fecal calprotectin. Liver fibrosis measured by transient elastography (TE) was assessed in the IBD-PSC group. Data was analyzed using general linear regression models and Spearman rank correlation tests. Patients with IBD-PSC had reduced microbial gene richness (p=0.004) and significant compositional shifts (PERMANOVA: R2=0.01, p=0.03) compared to IBD-only. IBD-PSC was associated with altered microbial composition and function, including decreased abundance of Blautia obeum, increased abundance of Veillonella atypica, Veillonella dispar and Clostridium scindens (q<0.05 for all), and increased abundance of microbial genes involved in secondary BA metabolism. Decreased serum sulfated and increased serum conjugated secondary BA were associated with IBD-PSC and increased liver fibrosis. We identified differences in microbial species, functional capacity and serum BA profiles in IBD-PSC compared with IBD-only. Our findings provide insight into the pathophysiology of IBD associated with PSC and suggest possible targets for modulating the risk and course of IBD in subjects with PSC.
- 9 July 2024
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 18 (12) , 1957-1966
Open AccessInflammatory Bowel Disease Associated with Primary Sclerosing Cholangitis is Associated with an Altered Gut Microbiome and Bile Acid Profile
Primary sclerosing cholangitis associated with inflammatory bowel disease (IBD-PSC) carries significant morbidity compared to IBD without PSC. Alterations in microbial composition and bile acid (BA) profiles have been shown to modulate chronic inflammation in IBD, but data in IBD-PSC is scarce. We aimed to assess the differences in gut microbiome composition as well as in the BA profile and BA-related microbial functions between IBD-PSC and IBD-only. 54 IBD-PSC and 62 IBD-only subjects were enrolled from 2012 to 2021. Baseline samples were collected for fecal DNA shotgun metagenomic sequencing, fecal and serum BA quantitation using mass spectrometry and fecal calprotectin. Liver fibrosis measured by transient elastography (TE) was assessed in the IBD-PSC group. Data was analyzed using general linear regression models and Spearman rank correlation tests. Patients with IBD-PSC had reduced microbial gene richness (p=0.004) and significant compositional shifts (PERMANOVA: R2=0.01, p=0.03) compared to IBD-only. IBD-PSC was associated with altered microbial composition and function, including decreased abundance of Blautia obeum, increased abundance of Veillonella atypica, Veillonella dispar and Clostridium scindens (q<0.05 for all), and increased abundance of microbial genes involved in secondary BA metabolism. Decreased serum sulfated and increased serum conjugated secondary BA were associated with IBD-PSC and increased liver fibrosis. We identified differences in microbial species, functional capacity and serum BA profiles in IBD-PSC compared with IBD-only. Our findings provide insight into the pathophysiology of IBD associated with PSC and suggest possible targets for modulating the risk and course of IBD in subjects with PSC.
- 4 July 2024
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 23 (4) , 612-620.e10
After Surgically Induced Remission, Ileal and Colonic Mucosa-Associated Microbiota Predicts Crohn’s Disease Recurrence
- 4 July 2024
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 23 (4) , 612-620.e10
After Surgically Induced Remission, Ileal and Colonic Mucosa-Associated Microbiota Predicts Crohn’s Disease Recurrence
- Open Access
- 3 October 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (19) , 14866
Genotype Prevalence of Lactose Deficiency, Vitamin D Deficiency, and the Vitamin D Receptor in a Chilean Inflammatory Bowel Disease Cohort: Insights from an Observational Study
Lactose intolerance (LI) and vitamin D deficiency (VDD) have been linked to inflammatory bowel disease (IBD). We conducted an observational study in 192 Chilean IBD patients to investigate the prevalence of a specific gene variant (LCT-13910 CC genotype) associated with LI and the prevalence of VDD/Vitamin D Receptor (VDR) gene variants. Blood samples were analyzed using Illumina’s Infinium Global Screening Array. The LCT-13910 CC genotype was found in 61% of IBD patients, similar to Chilean Hispanic controls and lower than Chilean Amerindian controls. The frequency of the LCT-13910-C allele in Chilean IBD patients (0.79) was comparable to the general population and higher than Europeans (0.49). Regarding VDR and VDD variants, in our study, the rs12785878-GG variant was associated with an increased risk of IBD (OR = 2.64, CI = 1.61–4.32; p-value = 0.001). Sixty-one percent of the Chilean IBD cohort have a genetic predisposition to lactose malabsorption, and a significant proportion exhibit genetic variants associated with VDD/VDR. Screening for LI and VDD is crucial in this Latin American IBD population.
- 3 October 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (19) , 14866
Open AccessGenotype Prevalence of Lactose Deficiency, Vitamin D Deficiency, and the Vitamin D Receptor in a Chilean Inflammatory Bowel Disease Cohort: Insights from an Observational Study
Lactose intolerance (LI) and vitamin D deficiency (VDD) have been linked to inflammatory bowel disease (IBD). We conducted an observational study in 192 Chilean IBD patients to investigate the prevalence of a specific gene variant (LCT-13910 CC genotype) associated with LI and the prevalence of VDD/Vitamin D Receptor (VDR) gene variants. Blood samples were analyzed using Illumina’s Infinium Global Screening Array. The LCT-13910 CC genotype was found in 61% of IBD patients, similar to Chilean Hispanic controls and lower than Chilean Amerindian controls. The frequency of the LCT-13910-C allele in Chilean IBD patients (0.79) was comparable to the general population and higher than Europeans (0.49). Regarding VDR and VDD variants, in our study, the rs12785878-GG variant was associated with an increased risk of IBD (OR = 2.64, CI = 1.61–4.32; p-value = 0.001). Sixty-one percent of the Chilean IBD cohort have a genetic predisposition to lactose malabsorption, and a significant proportion exhibit genetic variants associated with VDD/VDR. Screening for LI and VDD is crucial in this Latin American IBD population.
- 16 June 2022
- Published by Elsevier in Gastroenterology
- Vol. 162 (7)
Mo1515: THE TRANSCRIPTOMIC PROFILE OF THE NON-INFLAMED ILEUM IN CROHN’S DISEASE DIFFERS COMPARED TO THAT OF HEALTH CONTROLS
- 16 June 2022
- Published by Elsevier in Gastroenterology
- Vol. 162 (7)
Mo1515: THE TRANSCRIPTOMIC PROFILE OF THE NON-INFLAMED ILEUM IN CROHN’S DISEASE DIFFERS COMPARED TO THAT OF HEALTH CONTROLS